
|Videos|July 8, 2019
Targeting PD-1 in Non-Melanoma Skin Cancers
Skin Cancer
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Sacituzumab Govitecan Misses PFS in First-Line HR+/HER2– Metastatic Breast Cancer
2
First-in-Human Data Support Izalontamab in Advanced Epithelial Tumors
3
FDA Approves Subcutaneous Daratumumab for Smoldering Multiple Myeloma
4
Lurbinectedin and Tarlatamab in ES-SCLC
5





































